Literature DB >> 22927443

MicroRNA miR-214 regulates ovarian cancer cell stemness by targeting p53/Nanog.

Cheng-Xiong Xu1, Meng Xu, Lei Tan, Hua Yang, Jennifer Permuth-Wey, Patricia A Kruk, Robert M Wenham, Santo V Nicosia, Johnathan M Lancaster, Thomas A Sellers, Jin Q Cheng.   

Abstract

Previous studies have shown aberrant expression of miR-214 in human malignancy. Elevated miR-214 is associated with chemoresistance and metastasis. In this study, we identified miR-214 regulation of ovarian cancer stem cell (OCSC) properties by targeting p53/Nanog axis. Enforcing expression of miR-214 increases, whereas knockdown of miR-214 decreases, OCSC population and self-renewal as well as the Nanog level preferentially in wild-type p53 cell lines. Furthermore, we found that p53 is directly repressed by miR-214 and that miR-214 regulates Nanog through p53. Expression of p53 abrogated miR-214-induced OCSC properties. These data suggest the critical role of miR-214 in OCSC via regulation of the p53-Nanog axis and miR-214 as a therapeutic target for ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22927443      PMCID: PMC3471722          DOI: 10.1074/jbc.M112.374611

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

1.  p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression.

Authors:  Tongxiang Lin; Connie Chao; Shin'ichi Saito; Sharlyn J Mazur; Maureen E Murphy; Ettore Appella; Yang Xu
Journal:  Nat Cell Biol       Date:  2004-12-26       Impact factor: 28.824

Review 2.  Nanog and transcriptional networks in embryonic stem cell pluripotency.

Authors:  Guangjin Pan; James A Thomson
Journal:  Cell Res       Date:  2007-01       Impact factor: 25.617

3.  Zebrafish miR-214 modulates Hedgehog signaling to specify muscle cell fate.

Authors:  Alex S Flynt; Nan Li; Elizabeth J Thatcher; Lilianna Solnica-Krezel; James G Patton
Journal:  Nat Genet       Date:  2007-01-14       Impact factor: 38.330

4.  Expression of p53 in cisplatin-resistant ovarian cancer cell lines: modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV).

Authors:  G S Hagopian; G B Mills; A R Khokhar; R C Bast; Z H Siddik
Journal:  Clin Cancer Res       Date:  1999-03       Impact factor: 12.531

5.  Aurora-A abrogation of p53 DNA binding and transactivation activity by phosphorylation of serine 215.

Authors:  Qiyuan Liu; Satoshi Kaneko; Lin Yang; Richard I Feldman; Santo V Nicosia; Jiandong Chen; Jin Q Cheng
Journal:  J Biol Chem       Date:  2004-10-06       Impact factor: 5.157

6.  MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN.

Authors:  Hua Yang; William Kong; Lili He; Jian-Jun Zhao; Joshua D O'Donnell; Jiawang Wang; Robert M Wenham; Domenico Coppola; Patricia A Kruk; Santo V Nicosia; Jin Q Cheng
Journal:  Cancer Res       Date:  2008-01-15       Impact factor: 12.701

Review 7.  Oncomirs - microRNAs with a role in cancer.

Authors:  Aurora Esquela-Kerscher; Frank J Slack
Journal:  Nat Rev Cancer       Date:  2006-04       Impact factor: 60.716

8.  P53 enhances ascorbyl stearate-induced G2/M arrest of human ovarian cancer cells.

Authors:  K Akhilender Naidu; Quan Fang; Kamatham A Naidu; Jin Q Cheng; Santo V Nicosia; Domenico Coppola
Journal:  Anticancer Res       Date:  2007 Nov-Dec       Impact factor: 2.480

9.  Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer.

Authors:  Lorenzo F Sempere; Mette Christensen; Asli Silahtaroglu; Mads Bak; Catherine V Heath; Gary Schwartz; Wendy Wells; Sakari Kauppinen; Charles N Cole
Journal:  Cancer Res       Date:  2007-12-15       Impact factor: 12.701

10.  A microRNA expression signature of human solid tumors defines cancer gene targets.

Authors:  Stefano Volinia; George A Calin; Chang-Gong Liu; Stefan Ambs; Amelia Cimmino; Fabio Petrocca; Rosa Visone; Marilena Iorio; Claudia Roldo; Manuela Ferracin; Robyn L Prueitt; Nozumu Yanaihara; Giovanni Lanza; Aldo Scarpa; Andrea Vecchione; Massimo Negrini; Curtis C Harris; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-03       Impact factor: 11.205

View more
  54 in total

1.  The miR-106b~25 cluster promotes bypass of doxorubicin-induced senescence and increase in motility and invasion by targeting the E-cadherin transcriptional activator EP300.

Authors:  Y Zhou; Y Hu; M Yang; P Jat; K Li; Y Lombardo; D Xiong; R C Coombes; S Raguz; E Yagüe
Journal:  Cell Death Differ       Date:  2013-11-22       Impact factor: 15.828

2.  The overexpression of hypomethylated miR-663 induces chemotherapy resistance in human breast cancer cells by targeting heparin sulfate proteoglycan 2 (HSPG2).

Authors:  Haiyan Hu; Shuqin Li; Xiuying Cui; Xiaobin Lv; Yu Jiao; Fengyan Yu; Herui Yao; Erwei Song; Yongsong Chen; Minghui Wang; Ling Lin
Journal:  J Biol Chem       Date:  2013-02-22       Impact factor: 5.157

Review 3.  Molecular physiognomies and applications of adipose-derived stem cells.

Authors:  F Uzbas; I D May; A M Parisi; S K Thompson; A Kaya; A D Perkins; E Memili
Journal:  Stem Cell Rev Rep       Date:  2015-04       Impact factor: 5.739

Review 4.  MicroRNAs: master regulators of drug resistance, stemness, and metastasis.

Authors:  Umar Raza; Jitao David Zhang; Ozgür Sahin
Journal:  J Mol Med (Berl)       Date:  2014-02-09       Impact factor: 4.599

5.  Evolution of the miR199-214 cluster and vertebrate skeletal development.

Authors:  Thomas Desvignes; Adam Contreras; John H Postlethwait
Journal:  RNA Biol       Date:  2014-02-20       Impact factor: 4.652

Review 6.  Concise Review: NANOG in Cancer Stem Cells and Tumor Development: An Update and Outstanding Questions.

Authors:  Collene R Jeter; Tao Yang; Junchen Wang; Hsueh-Ping Chao; Dean G Tang
Journal:  Stem Cells       Date:  2015-05-13       Impact factor: 6.277

7.  miR-106a represses the Rb tumor suppressor p130 to regulate cellular proliferation and differentiation in high-grade serous ovarian carcinoma.

Authors:  Zhaojian Liu; Elizabeth Gersbach; Xiyu Zhang; Xiaofei Xu; Ruifen Dong; Peng Lee; Jinsong Liu; Beihua Kong; Changshun Shao; Jian-Jun Wei
Journal:  Mol Cancer Res       Date:  2013-09-17       Impact factor: 5.852

Review 8.  Intratumoral heterogeneity: Clonal cooperation in epithelial-to-mesenchymal transition and metastasis.

Authors:  Deepika Neelakantan; David J Drasin; Heide L Ford
Journal:  Cell Adh Migr       Date:  2014-10-16       Impact factor: 3.405

9.  miR-214-mediated downregulation of RNF8 induces chromosomal instability in ovarian cancer cells.

Authors:  Zheng Wang; Hao Yin; Yuanwei Zhang; Yukun Feng; Zhaofeng Yan; Xiaohua Jiang; Ihtisham Bukhari; Furhan Iqbal; Howard J Cooke; Qinghua Shi
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 10.  MicroRNAs in cancer stem cells: current status and future directions.

Authors:  Ravindresh Chhabra; Neeru Saini
Journal:  Tumour Biol       Date:  2014-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.